Legal Opinion
United States ex rel. Kester v. Novartis Pharmaceuticals Corp.
District Court, S.D. New York
Decided September 3, 2014No. 11 Civ. 8196(CM)PublishedCited by 29 opinions
1Opinion of the Court
MEMORANDUM DECISION AND ORDER GRANTING IN PART AND DENYING IN PART DEFENDANTS’ MOTIONS TO DISMISS
McMAHON, District Judge:
Plaintiff-relator David M. Kester (“Relator”) filed a sealed qui tam action asserting claims arising under the False Claims Act (“FCA”), 31 U.S.C. § 3729 et seq., and related state laws. The Defendants named in the complaint include Novartis Pharmaceuticals Corporation (“Novartis”) and certain specialty pharmacies, including CVS Caremark Corporation (“Caremark”), Accredo Health Group, Inc. (“Accredo”), and Curascript, Inc. (“Curascript”) (collectively, the “Pharmacy…
2Cases cited41 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Gonzalez v. ThalerSupreme Court of the United States · 2012
- Natalia Makarova v. United StatesCourt of Appeals for the Second Circuit · 2000
- Vermont Agency of Natural Resources v. United States Ex Rel. StevensSupreme Court of the United States · 2000
36 more not listed; retrieve them via the Exa API.
3Cited by29 opinions
- Guilfoile v. ShieldsCourt of Appeals for the First Circuit · 2019
- United States Ex Rel. Ibanez v. Bristol-Myers Squibb Co.Court of Appeals for the Sixth Circuit · 2017
- United States ex rel. Wood v. Allergan, Inc.District Court, S.D. New York · 2017
- United States ex rel. Kolchinsky v. Moody's Corp.District Court, S.D. New York · 2016
- United States v. Mount Sinai HospitalDistrict Court, S.D. New York · 2017
24 more not listed; retrieve them via the Exa API.